← SynDRA

TANDUTINIB

SynDRA canonical compound SYN0004466 — structure-anchored drug synonym record

All known targets

• FLT3
• KIT
• PDGFRB
• PDGFRA
• CSF1R
• PDGFD

Mechanisms of action (all sources)

• KIT INHIBITOR
• FLT3 INHIBITOR
• PDGFR inhibitor
• Tyrosine-protein kinase receptor FLT3 inhibitor
• Stem cell growth factor receptor inhibitor
• PDGFRB INHIBITOR
• Platelet-derived growth factor receptor beta inhibitor
• PDGFR tyrosine kinase receptor inhibitor

Cross-references

• PubChem CID: 3038522
• ChEMBL: CHEMBL124660
• DrugBank: DB05465
• ChEBI: 90237
• KEGG: D06005
• TTD: D0IT6Q
• LINCS BRD: BRD-K89162000

Synonyms

• Mln-0518
• CT-53518
• CT53518
• MLN-518
• NSC-759851
• MLN-0518
• MLN518, CT53518
• Tandutinib (USAN/INN)
• (4-(6-Methoxy-7-(3-piperidylpropoxy)quinazolin-4-yl)piperazinyl)-N-(4-(methylethoxy)phenyl)carboxamide
• 4-(6-Methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-yl)piperazine-1-carboxylic acid (4-isopropoxyphenyl)amide
• 4-[6-methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-yl]-N-(4-propan-2-yloxyphenyl)piperazine-1-carboxamide
• MLN 518
• MLN518
• Tandutinib (MLN518)
• N-(4-isopropoxyphenyl)-4-(6-methoxy-7-(3-(piperidin-1-yl)propoxy)quinazolin-4-yl)piperazine-1-carboxamide
• E1IO3ICJ9A
• NSC 759851
• CHEMBL124660
• CHEBI:90237
• NSC726292
• NCGC00241097-01
• D06005
• 4-{6-methoxy-7-[3-(piperidin-1-yl)propoxy]quinazolin-4-yl}-N-[4-(propan-2-yloxy)phenyl]piperazine-1-carboxamide
• Tandutinib [USAN]
• CAS-387867-13-2
• Tandutinib [USAN:INN]
• UNII-E1IO3ICJ9A
• Tandutinib(CT 53518)
• tandutinibum
• 4-(6-Methoxy-7-(3-(piperidin-1-yl)propoxy)quinazolin-4-yl)-N-(4-(1-methylethoxy)phenyl)piperazine-1-carboxamide
• 4-[6-Methoxy-7-[3-(piperidin-1-yl)propoxy]quinazolin-4-yl]-N-[4-(1-methylethoxy)phenyl]piperazine-1-carboxamide
• MFCD09954147
• Kinome_3320
• MLN518, Tandutinib
• Tandutinib(MLN518)
• Tandutinib - MLN518
• TANDUTINIB [INN]
• TANDUTINIB [WHO-DD]